Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.
Department of Molecular Biology and Pharmacology, Washington University Medical School, Campus Box 8103, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
K
K
Yu
D M
DM
Ornitz
D000168:Acrocephalosyndactylia / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D004195:Disease Models, Animal; D005346:Fibroblast Growth Factors / Q000378:metabolism; D006801:Humans; D008024:Ligands; D051379:Mice; D009154:Mutation; D010641:Phenotype; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics / Q000378:metabolism*; D051497:Receptor, Fibroblast Growth Factor, Type 2; D017468:Receptors, Fibroblast Growth Factor / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction
D008024:Ligands; D017468:Receptors, Fibroblast Growth Factor; D005346:Fibroblast Growth Factors; C496353:FGFR2 protein, human; C496354:Fgfr2 protein, mouse; D020794:Receptor Protein-Tyrosine Kinases; D051497:Receptor, Fibroblast Growth Factor, Type 2